z-logo
open-access-imgOpen Access
Acceleration of Biliary Cholesterol Secretion Restores Glycemic Control and Alleviates Hypertriglyceridemia in Obese db / db Mice
Author(s) -
Kai Su,
Nadezhda Sabeva,
Yuhuan Wang,
Xiaoxi Liu,
Joshua Lester,
Jingjing Liu,
Shuang Liang,
Gregory A. Graf
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302355
Subject(s) - medicine , endocrinology , insulin resistance , cholesterol , nonalcoholic fatty liver disease , steatosis , hypertriglyceridemia , insulin , biology , fatty liver , glycemic , triglyceride , disease
Recent studies support a role for cholesterol in the development of obesity and nonalcoholic fatty liver disease. Mice lacking the ABCG5 ABCG8 (G5G8) sterol transporter have reduced biliary cholesterol secretion and are more susceptible to steatosis, hepatic insulin resistance, and loss of glycemic control when challenged with a high-fat diet. We hypothesized that accelerating G5G8-mediated biliary cholesterol secretion would correct these phenotypes in obese mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom